Daniel Cooper
About Daniel Cooper
Daniel Cooper is a Medical Science Liaison specializing in Cell Therapy at Bristol Myers Squibb, with a background in oncology, biochemical nutrition, and biochemistry.
Professional Background
Daniel Cooper has extensive experience in the medical and pharmaceutical industries. He currently works as a Medical Science Liaison specializing in Cell Therapy at Bristol Myers Squibb. Prior to this role, he served as a Medical Science Liaison in Oncology for Bristol Myers Squibb in the Mid-Atlantic region, covering VA, DC, MD, and DE, from 2019 to 2022. He also worked as a Study Director at Metabolon, Inc. in RTP for 10 months from 2018 to 2019 and as a Postdoctoral Fellow at Duke University Medical Center from 2015 to 2018. His early career includes a role as a Research Associate at Vertex Pharmaceuticals from 2005 to 2010.
Educational Background
Daniel Cooper has a strong educational foundation in biochemistry and nutrition. He earned a Doctor of Philosophy (PhD) in Biochemical Nutrition from the University of North Carolina at Chapel Hill, where he studied from 2010 to 2015. Prior to that, he completed a Bachelor of Science (BS) in Biochemistry and Cell Biology at the University of California, San Diego, studying from 2003 to 2008.
Roles and Responsibilities
In his current role at Bristol Myers Squibb, Daniel Cooper focuses on CAR-T therapies specifically targeting Multiple Myeloma and Lymphoma. He has led the launch of four new therapies in hematology/oncology and organized three advisory boards to gather expert insights for strategic decision-making. As the Medical Affairs lead for an established brand, he has played a crucial role in ensuring its ongoing market success. He has also served as a clinical trial lead, overseeing the execution and progress of clinical studies.
Recognitions and Awards
Daniel Cooper has been recognized for his contributions and achievements in the field. He received the FM Accountability Award for two consecutive years, reflecting the respect and recognition of his peers in field medical. His efforts in training his MSL team have also been notable, as he has enhanced their skills and knowledge, contributing to the overall success of his team.